Susquehanna Fundamental Investments, LLC Legend Biotech Corp Transaction History

Susquehanna Fundamental Investments, LLC

  • $4.33 Trillion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$55.06 - $69.99 $1.91 Million - $2.43 Million
34,746 New
34,746 $1.95 Billion
Q1 2022

May 16, 2022
SELL
$31.02 - $48.18 $286,686 - $445,279
-9,242 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$41.14 - $56.98 $17,278 - $23,931
-420 Reduced 4.35%
9,242 $431,000
Q3 2021

Nov 15, 2021
BUY
$35.31 - $50.56 $152,609 - $218,520
4,322 Added 80.94%
9,662 $489,000
Q2 2021

Aug 11, 2021
BUY
$25.8 - $41.09 $137,772 - $219,420
5,340 New
5,340 $219,000

Others Institutions Holding LEGN

# of Institutions
212
Shares Held
77.9M
Call Options Held
412K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email